Article Details

Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive ...

Retrieved on: 2024-04-18 01:24:18

Tags for this article:

Click the tags to see associated articles and topics

Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive .... View article details on HISWAI: https://investor.lilly.com/news-releases/news-release-details/tirzepatide-reduced-sleep-apnea-severity-nearly-two-thirds

Summary

Tirzepatide, a biotechnology product by Eli Lilly and Company, demonstrated up to 63% reduction in the apnea-hypopnea index for sleep apnea, indicating significant improvement for sleep disorders like obstructive sleep apnea.

Article found on: investor.lilly.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up